Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2).
Shirakawa T, Shimokawa M, Otsuka T, Shinohara Y, Toyodome K, Kusano W, Nakazawa J, Kodama T, Kawahira M, Shimokawa H, Koike T, Koga F, Yunotani S, Nakashita S, Oza N, Noge S, Murayama K, Oda H, Mitsui N, Kawasaki R, Morikita T, Takeshita S, Arima S, Shibata R, Kakihara A, Yoshihiro T, Imajima T, Yamaga S, Arita S, Kawaguchi Y, Nishikawa K, Inagaki T, Otsu S, Taguchi H, Jikuya K, Terada T, Sakai T, Ueda Y, Sakae T, Sawase H, Kawahira M, Nio K, Araki N, Sakai K, Ide Y, Shibuki T, Miwa K, Kubotsu Y, Hosokawa A, Komori A, Honda T, Tsuneyoshi K, Fujita T, Mizuta T, Mitsugi K.
Shirakawa T, et al. Among authors: sakai k.
ESMO Gastrointest Oncol. 2025 Feb 27;8:100150. doi: 10.1016/j.esmogo.2025.100150. eCollection 2025 Jun.
ESMO Gastrointest Oncol. 2025.
PMID: 41646280
Free PMC article.